Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Solazyme Inc Agrees To Dissolve Joint Venture With Roquette Freres, S.A
Solazyme Inc announced that it has agreed with Roquette Frères, S.A. to dissolve joint venture, Solazyme Roquette Nutritionals, LLC, in accordance with their Joint Venture and Operating Agreement dated November 3, 2010, by and between Roquette and Solazyme. The parties expect the formal dissolution to occur in the coming weeks. The decision to terminate the joint venture was driven by divergent views on an acceptable commercial strategy and timeline for the manufacturing and marketing of joint venture products. As a result, Solazyme intends to accelerate commercialization of suite of microalgal food ingredients.
Latest Developments for Solazyme Inc
- Solazyme Inc Reaffirms FY 2013 Revenue Guidance-Conference Call
- Solazyme Inc Issues FY 2013 Revenue Guidance Below Analysts' Estimates-Conference Call
- Solazyme Inc Issues FY 2012 Revenue Guidance Below Analysts' Estimates-Conference Call
- Solazyme Inc Lowers Low End Of Prior FY 2012 Revenue Guidance-Conference Call
- Share this
- Link this
- Digg this


Follow Reuters